Zuga Matt - Insider Non-Derivative Transactions at Acumen Pharmaceuticals, Inc. (ABOS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 18, 2024, Zuga Matt's relationship to Acumen Pharmaceuticals, Inc. (ABOS) is Officer (CFO & Chief Business Officer), and currently has 211,445 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ABOS insiders.
Data Source: SEC.
Zuga Matt - Insider Non-Derivative Transactions of ABOS Common Stock
Zuga Matt - Insider Non-Derivative Transactions at ABOS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 19, 2024 | Sell -- (Common Stock) | 4242 | 3.71 | 211445 |
| Jan 3, 2024 | Acquisition -- (Common Stock) | 106000 | 0 | 215687 |
| Jan 18, 2023 | Acquisition -- (Common Stock) | 33500 | 0 | 109687 |
| Dec 30, 2022 | M -- (Common Stock) | 50000 | 1.19 | 76187 |